Advanced search
Publication Cover
Current Medical Research and Opinion Volume 34, 2018 - Issue 10
Submit an article Journal homepage
473
Views
12
CrossRef citations to date
0
Altmetric
Neurology

First-line disease-modifying drugs in relapsing–remitting multiple sclerosis: an Italian real-life multicenter study on persistence

Diana FerraroDepartment of Neurosciences, Ospedale Civile, Azienda Ospedaliero-Universitaria, Modena, Italy; ;Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy; Correspondence[email protected]
,
Valentina CameraDepartment of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy;
,
Eleonora BaldiNeurology Unit, Department of Neuroscience/Rehabilitation, Azienda Ospedaliera-Universitaria S. Anna, Ferrara, Italy;
,
Veria VacchianoDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy;
,
Erica CurtiNeurology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy;
,
Angelica GuareschiNeurology Unit, Vaio-Fidenza Hospital, Parma, Italy;
,
Susanna MalagùNeurology Unit, Bufalini Hospital, Cesena, Italy;
,
Sara MontepietraNeurology Unit, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy;
,
Silvia StrumiaNeurology Unit, Ospedale G.B. Morgagni–L. Pierantoni, Forlì, Italy;
,
Mario SantangeloNeurology Unit, Ospedale Ramazzini, Carpi, Modena, Italy;
,
Luisa CaniattiNeurology Unit, Department of Neuroscience/Rehabilitation, Azienda Ospedaliera-Universitaria S. Anna, Ferrara, Italy;
,
Matteo FoschiDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy;
,
Alessandra LugaresiDepartment of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy; ;IRCCS, Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy;
,
Franco GranellaNeurology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy;
,
Ilaria PesciNeurology Unit, Vaio-Fidenza Hospital, Parma, Italy;
,
Luisa MottiNeurology Unit, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Italy;
,
Walter NeriNeurology Unit, Ospedale G.B. Morgagni–L. Pierantoni, Forlì, Italy;
,
Paolo ImmovilliNeurology Unit, Department of Specialistic Medicine, G. da Saliceto Hospital, Piacenza, Italy;
,
Enrico MontanariPolo Neurologico Interaziendale, Parma, Italy
,
Francesca VitettaDepartment of Neurosciences, Ospedale Civile, Azienda Ospedaliero-Universitaria, Modena, Italy;
,
Anna Maria SimoneDepartment of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy;
&
Patrizia SolaDepartment of Neurosciences, Ospedale Civile, Azienda Ospedaliero-Universitaria, Modena, Italy;
show all
Pages 1803-1807 | Received 05 Dec 2017, Accepted 08 Mar 2018, Published online: 12 Apr 2018

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jagadeswara R Earla, George J Hutton, J Douglas Thornton, Hua Chen, Michael L Johnson & Rajender R Aparasu. (2020) Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis. Patient Preference and Adherence 14, pages 2187-2199.
Read now

Articles from other publishers (11)

Carla Cecília Nunes, Pedro Abreu, Filipe Correia, Irene Mendes & Ana Martins da Silva. (2023) Teriflunomide treatment outcomes in multiple sclerosis: A Portuguese real-life experience. Brain and Neuroscience Advances 7.
Crossref
Rashed Bawand, Masoud Ghiasian, Negin Fathoallahi & Abbas Moradi. (2022) Effects of disease-modifying treatments discontinuation in patients with relapsing-remitting multiple sclerosis: A 5 year prospective cohort study. Multiple Sclerosis and Related Disorders 63, pages 103857.
Crossref
Jacqueline A Nicholas, Natalie C Edwards, Roger A Edwards, Anna Dellarole, Luigi Manca, Danielle E Harlow & Amy L Phillips. (2022) Static and group-based trajectory analyses of factors associated with non-adherence in patients with multiple sclerosis newly-initiating once- or twice-daily oral disease-modifying therapy. Multiple Sclerosis Journal - Experimental, Translational and Clinical 8:2, pages 205521732211011.
Crossref
Jiwon Oh, Bryan Walker, Gavin Giovannoni, Dominic Jack, Fernando Dangond, Axel Nolting, Julie Aldridge, Lori A Lebson & Thomas P Leist. (2021) Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical 7:3, pages 205521732110242.
Crossref
Per Soelberg Sorensen, Tine Iskov Kopp, Hanna Joensen, Anna Olsson, Finn Sellebjerg & Melinda Magyari. (2021) Age and sex as determinants of treatment decisions in patients with relapsing-remitting MS. Multiple Sclerosis and Related Disorders 50, pages 102813.
Crossref
Matteo Foschi, Giulia Giannini, Elena Merli, Luca Mancinelli, Corrado Zenesini, Beatrice Viti, Pietro Guaraldi, Pietro Cortelli & Alessandra Lugaresi. (2020) Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31. Neurological Sciences 42:4, pages 1395-1403.
Crossref
Jacqueline A. Nicholas, Natalie C. Edwards, Roger A. Edwards, Anna Dellarole, Megan Grosso & Amy L. Phillips. (2020) Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis. BMC Neurology 20:1.
Crossref
Chiara Zecca, Adam Czaplinski, Christophe Henny, Liliane Petrini, Andreas Beeler & Claudio Gobbi. (2020) SwissTecLive: effectiveness and safety of dimethyl fumarate in the treatment of RRMS in the Swiss clinical practice setting. Heliyon 6:12, pages e05819.
Crossref
Antonio Marangi, Gabriele Farina, Virginia Vicenzi, Stefano Forlivesi, Francesca Calabria, Fabio Marchioretto, Antonio Forgione, Francesca Rossi, Gianola Stenta, Marika Vianello, Alberto Gajofatto & Maria Donata Benedetti. (2020) Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy. Multiple Sclerosis and Related Disorders 41, pages 102004.
Crossref
L.A. Visser, C. Louapre, C.A. Uyl-de Groot & W.K. Redekop. (2020) Patient needs and preferences in relapsing-remitting multiple sclerosis: A systematic review. Multiple Sclerosis and Related Disorders 39, pages 101929.
Crossref
Daniel R. Wynn. (2019) Enduring Clinical Value of Copaxone® (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of Use. Multiple Sclerosis International 2019, pages 1-19.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.